Indian Lung Screening Trial

Evaluating LDCT lung cancer screening in high-risk Indians & the care pathways that follow. Early detection saves lives. 🫁

[Indian Lung Screening Trial @LungHealthIndia]

🫁 Could you be at high risk for lung cancer?

Lung cancer remains a major public health concern, but it often shows no obvious symptoms in its early stages. For those at increased risk due to age and smoking history, LDCT screening offers a real opportunity for earlier detection

[Indian Lung Screening Trial @LungHealthIndia]

🫁 NLST (NEJM, 2011): landmark trial, 53,454 high-risk participants, 33 US centres.

LDCT vs chest X-ray screening showed 20% reduction in lung-cancer mortality, 6.7% reduction in all-cause mortality.

🔗 https://t.co/wckz1OHQJw

#LungCancerScreening #NLST

[Indian Lung Screening Trial @LungHealthIndia]

🧬 Meet Our Team | Dr. Ashish Datt Upadhyay
Co-Principal Investigator, Indian Lung Screening Trial (ILST)
Research Scientist-II, Biostatistics,
@aiims_newdelhi

His work shapes the statistical backbone of our trial 🧵👇
#MeetOurTeam #IndianLungScreeningTrial

[Indian Lung Screening Trial @LungHealthIndia]

🫁 Lung cancer is a major public health challenge in India.

2024: 112,659 new cases (7.2% of all cancers), 98,687 deaths (GLOBOCAN 2024).

Know the risk. Know the role of screening. 🧵

📲 Follow @LungHealthIndia for more.

#LungCancerScreening #LDCT #ILST

[Indian Lung Screening Trial @LungHealthIndia]

🧬 Meet Dr. Sachidanand Jee Bharati, Professor, Onco-Anaesthesia & Palliative Medicine, AIIMS Delhi.

His work spans ICU care after cancer surgery, ERAS protocols & end-of-life care - improving recovery for cancer patients.

#MeetOurTeam #CancerCare

[Indian Lung Screening Trial @LungHealthIndia]

First study to combine diagnostic, operational, economic & behavioral outcomes from an LDCT program in an SE Asian LMIC - a transferable template for countries facing similar late-stage diagnosis burdens.

📄 Le et al., Lung Cancer, 2026
🔗 https://t.co/FPw5rlCfiy

[Indian Lung Screening Trial @LungHealthIndia]

On 16 Sept 2026, our team met with Catharine Grimes (President) & Mason Chiang (Assoc. Director), Bristol Myers Squibb Foundation @bmsnews, to discuss Indian Lung Screening Trial project and Air Pollution & Cancer Research Ecosystem project.

Grateful for their collaboration. 🫁

[Indian Lung Screening Trial @LungHealthIndia]

🩺 Meet Dr. Sunil Kumar, Professor & Head, Surgical Oncology, @aiims_newdelhi

A leading lung cancer surgeon steering the Delhi Cancer Registry - shaping both patient care & population-level cancer control in India.

#MeetOurTeam #AIIMS #LungCancer

[Indian Lung Screening Trial @LungHealthIndia]

🫁 Lung cancer isn't just a "smoker's disease."

Risk factors include: smoking, second-hand smoke, occupational exposures (asbestos, silica), air pollution, radon gas & family history.

Know your risk. Early detection saves lives. 🎗️

#LungCancerAwareness #EarlyDetection

[Indian Lung Screening Trial @LungHealthIndia]

Meet Dr. Mayank Singh, Additional Professor, Medical Oncology(Lab), @aiims_newdelhi

His research explores epigenetic modifications in the DNA damage response to find new therapeutic targets, CAR-T cell & cellular immunotherapy for cancers, and liquid biopsy for early detection.

[Indian Lung Screening Trial @LungHealthIndia]

📊 New evidence keeps building the case for lung cancer screening.

The NELSON Trial (NEJM, 2020) found volume-based LDCT screening reduced lung-cancer mortality by 24% over 10 years in 15,792 high-risk smokers (RR 0.76, 95% CI 0.61–0.94).

🔗 https://t.co/gnxc4MDOi1 🧵

[Indian Lung Screening Trial @LungHealthIndia]

🫁 Meet Dr. Chandra Prakash Prasad, Addl. Professor, Medical Oncology (Lab), AIIMS Delhi.

Expertise: Wnt signalling, cancer cell metabolism, cancer stem cell biology & drug design/therapeutics - 4,000+ citations. Strengthening our lung cancer research.

#MeetOurTeam #AIIMS

[Indian Lung Screening Trial @LungHealthIndia]

"The Weight We Don't Always See" 🤍

Addiction doesn't always look like a cage. Sometimes it's a habit - a cigarette, a pill, a moment of escape that slowly becomes a daily burden.

Don't judge. Notice. Reach out.

#AddictionAwareness #SayNoToTobacco

[Indian Lung Screening Trial @LungHealthIndia]

🫁 No symptoms doesn't mean no disease.

Lung cancer can develop silently. A Low-Dose CT (LDCT) scan can detect it before symptoms appear.

Eligible: 50-80 yrs, 20+ pack-year smoking history, current/quit within 15 yrs.

Talk to your doctor. 💙

#LungCancerScreening #LDCT

[Indian Lung Screening Trial @LungHealthIndia]

👩‍⚕️ MEET OUR TEAM | Co-PI

Dr. Rambha Pandey, Professor, Radiation Oncology, DRBRIRCH, AIIMS Delhi - bringing valuable clinical & academic insight to our lung cancer research & screening efforts. 🫁

#MeetOurTeam #LungCancerResearch #AIIMS

[Indian Lung Screening Trial @LungHealthIndia]

देर मत कीजिए। हर साँस ज़रूरी है। ❤️

Lung cancer can develop silently. If something doesn't feel right, don't wait.

🫁 Know your risk. Recognise the signs. Talk to your doctor.

SCREEN TODAY. SECURE TOMORROW.

#LungCancerAwareness #EarlyDetection

[Indian Lung Screening Trial @LungHealthIndia]

Every breath is a gift. 🫁

Lung cancer often goes undetected until it's advanced. LDCT screening can catch it earlier - when there's more hope, more time, more moments with the ones you love.

"Every Breath is a Moment. Protect It." 💙

#lungcancerscreening #lungcancerawareness

[Indian Lung Screening Trial @LungHealthIndia]

Behind every research initiative is a team driven by knowledge & commitment to better health outcomes.

Meet Dr. @ShankarAbhishek, Principal Investigator, with expertise in Radiation Oncology & cancer prevention - driving our work in cancer care & research.

#lungcancerresearch

[Indian Lung Screening Trial @LungHealthIndia]

✨ Awareness is the first step.
✨ Early detection saves lives.
✨ Better outcomes bring hope.

Let's break the myths and talk about lung cancer - for smokers and non-smokers alike.

🫁 YOUR LUNGS. YOUR HEALTH. YOUR FUTURE.

@aiims_newdelhi @AmericanCancer @ics_1951

#SaveLives

[Indian Lung Screening Trial @LungHealthIndia]

🫁 The Indian Lung Screening Trial evaluates Low-Dose CT (LDCT) screening for high-risk adults (50-80, 20+ pack-yr smoking history) in India - from early detection to full care pathway.

Screening is the first step. Care is the journey.

#LungCancerScreening #LDCT #CancerResearch